1. Home
  2. LIQT vs KYNB Comparison

LIQT vs KYNB Comparison

Compare LIQT & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$0.90

Market Cap

28.8M

Sector

Technology

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$6.75

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIQT
KYNB
Founded
2004
1993
Country
Denmark
United States
Employees
N/A
34
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.8M
27.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
LIQT
KYNB
Price
$0.90
$6.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.30
N/A
AVG Volume (30 Days)
353.8K
31.1K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.12
N/A
Revenue Next Year
$63.48
N/A
P/E Ratio
N/A
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$6.32
52 Week High
$3.35
$9.58

Technical Indicators

Market Signals
Indicator
LIQT
KYNB
Relative Strength Index (RSI) 34.74 49.21
Support Level $0.74 $6.58
Resistance Level $2.03 $7.41
Average True Range (ATR) 0.14 0.30
MACD 0.02 0.01
Stochastic Oscillator 26.86 22.14

Price Performance

Historical Comparison
LIQT
KYNB

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: